Search

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

An in-vivo study demonstrates that Vcaps® Plus capsules are equivalent to gelatin in terms of human pharmacokinetics profile.

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?

Implementing green practices in clinical trials.

Oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

The use of adenovirus-associated virus (AAV) vectors in gene therapy is growing.

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.